Amneal Pharmaceuticals has just seen its fair value estimate nudged to US$14.00 from US$13.80, a small but meaningful reset that ties directly to how the latest quarterly numbers stack up against ...

MADRID, Dec. 22, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: ...

Sandoz has launched Wyost® (denosumab 120 mg) and Jubbonti® (denosumab 60 mg) across Europe, among the first denosumab biosimilars approved for all Xgeva® and Prolia® indications, targeting ...

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare today announced the launch ...

Findings showed denosumab-qbde demonstrated comparable quality, efficacy, safety, and immunogenicity to the reference product. Enoby is approved to treat postmenopausal women with osteoporosis at high ...

Earlier this year, Fresenius announced Fresenius Kabi reached a global settlement with Amgen concerning its denosumab biosimilars. A Q-code is a CMS reimbursement code used by healthcare providers and ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--#CommittedToLife--Fresenius Kabi, a part of the global healthcare company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) ...

Bosaya and Aukelso are FDA-approved biosimilars for managing bone health in cancer patients, offering cost-effective alternatives to Prolia and Xgeva. Bosaya targets bone loss prevention in prostate ...

Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Aukelso is indicated to prevent skeletal-related events in patients with multiple myeloma ...

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Organon & Co. stands eleventh among them. Organon & Co. (NYSE:OGN), a global healthcare company focused on women ...

Bildyos is supplied as a 60mg/mL single-dose prefilled syringe and single-dose vial; Bilprevda is supplied as a 120mg/1.7mL single-dose vial. Bildyos is approved to treat postmenopausal women with ...